早期的术后肝功能参数作为肝切除术后肝衰竭的预测指标
Schaima Abdelhadi1, Mohamad El-Ahmar1, Katharina Vedder1
1Department of Surgery, Universitätsmedizin Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Frontiers in surgery
|November 6, 2025
概括
早期检测肝切除术后肝衰竭 (PHLF) 是非常重要的. 术后第三天的肝功能测试,包括胆红素和INR,可以预测PHLF的发展,使得及时干预.
科学领域:
- 肝胆道手术 肝胆道手术
- 手术结果研究研究.
- 肝功能监测 监测肝功能
背景情况:
- 肝切除术后肝衰竭 (PHLF) 是肝切除后的一种严重并发症,与高发病率和死亡率有关.
- 目前的诊断标准 (ISGLS) 依赖于手术后第5天 (POD) 的实验室值,这可能会延迟关键干预.
研究的目的:
- 评估早期术后肝功能参数对PHLF发展的预测值.
- 在POD 3上确定PHLF早期指标的最佳切断点.
主要方法:
- 对445名接受选择性肝切除术的患者进行了回顾性分析.
- 在POD1,3和5上测量胆红素,INR,AST和ALT.
- 后勤回归和ROC分析,以确定PHLF的独立预测因子和最佳切线.
主要成果:
- 在8.5%的患者中出现PHLF.
- 从POD1开始,在患有PHLF的患者中观察到显著升高的胆红素,INR,AST和ALT.
- 在POD3上,胆红素 (≥1.8 mg/dl),INR (≥1.18),AST (≥179 U/L) 和ALT (≥258 U/L) 的特定切断值显示了PHLF的显著预测值.
- 大型肝切除术,POD3胆红素和INR,以及持续升高的亚胺转酶是PHLF的独立预测因素.
结论:
- 在POD3上胆红素和INR是PHLF的强有力的独立预测因素.
- 在POD3上早期评估肝功能可以帮助预测PHLF,可能改善患者的治疗结果.
- 在POD3上增加的转氨酶也可以作为有价值的预后指标,建议将它们纳入未来的PHLF定义.
关键词:
在INR中,INR就是INR.这就是ISGLS.在 PHLF 的情况下,PHLF 是胆红素是什么意思 胆红素是什么意思早期预测 早期预测肝功能衰竭 肝功能衰竭 肝功能衰竭肝脏切除切除 肝脏切除转氨酶的使用方法更多相关视频
18:47Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction
Published on: March 7, 2013
37.2K
07:29Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
15.4K
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
171
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
208
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208
